These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6090762)

  • 21. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
    Masuda N
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
    Joss RA; Obrecht JP; Jungi WF; Alberto P; Sauter C; Cavalli F
    Cancer Chemother Pharmacol; 1984; 13(2):148-9. PubMed ID: 6088102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study on vindesine plus cisplatin treatment of advanced non-small cell lung cancer--three divided doses (35 mg/m2, day 1, 8, 15) and single dose (80 mg/m2, day 1) of cisplatin. Chiba Lung Cancer Study Group].
    Nagao K; Fujisawa T; Miyamoto T; Kikuchi N; Takizawa H; Satoh K; Yamagishi F; Yamaguchi T; Mizutani F; Nakano K
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):425-30. PubMed ID: 1848421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
    Gatzemeier U; Zschaber R; Hossfeld DK; Radenbach D
    Onkologie; 1984 Oct; 7(5):308-15. PubMed ID: 6392971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized trial of combination vindesine and cisplatin versus single-agent vindesine in advanced non-small cell lung cancer.
    Popkin JD; Hong WK; Cersosimo RJ; Faling LJ; Snow MN; Fofonoff SA
    Pharmacotherapy; 1985; 5(1):20-2. PubMed ID: 3885173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P; Manke HG
    Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
    Gralla RJ; Casper ES; Kelsen DP; Braun DW; Dukeman ME; Martini N; Young CW; Golbey RB
    Ann Intern Med; 1981 Oct; 95(4):414-20. PubMed ID: 7025719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
    Akiyama J; Sato A; Honda K; Chida K; Watanabe T; Okano H; Okano A; Taniguchi M; Genma H; Aoki H
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):419-24. PubMed ID: 1848420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.
    Delaloye JF; Leyvraz S; Outcha Adjahoto E; Bauer J; De Grandi P
    Am J Clin Oncol; 1996 Apr; 19(2):204-6. PubMed ID: 8610651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
    Voigt H; Kleeberg UR
    Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
    Kelsen DP; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
    Cancer; 1982 Mar; 49(6):1174-7. PubMed ID: 6174199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
    Stuart-Harris R; Fox RM; Raghavan D; Coates AS; Hedley D; Levi JA; Woods RL; Tattersall MH
    Thorax; 1985 May; 40(5):346-50. PubMed ID: 2410994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.